These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29093000)

  • 21. How much "spread" in AWP pricing is unlawful?
    Rubinstein E; Curtiss FR
    J Manag Care Pharm; 2007; 13(6):515-6. PubMed ID: 17672813
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug industry is considering more use of differential pricing, conference hears.
    Sukkar E
    BMJ; 2011 Dec; 343():d8049. PubMed ID: 22155726
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceutical pricing conundrum: time to get rid of it?
    Garattini L; Padula A
    Eur J Health Econ; 2018 Nov; 19(8):1035-1038. PubMed ID: 30030646
    [No Abstract]   [Full Text] [Related]  

  • 24. Convergence of decision rules for value-based pricing of new innovative drugs.
    Gandjour A
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):209-13. PubMed ID: 25327543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 26. The future of prescription drug cost-sharing: real progress or dropped opportunity?
    Fairman KA
    J Manag Care Pharm; 2008; 14(1):70-82. PubMed ID: 18240885
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceutical expenditure in Spain: cost and control.
    Lopez Bastida J; Mossialos E
    Int J Health Serv; 2000; 30(3):597-616. PubMed ID: 11109184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. South Africa's moral victory.
    Lancet; 2001 Apr; 357(9265):1303. PubMed ID: 11343727
    [No Abstract]   [Full Text] [Related]  

  • 29. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 30. The European value-pricing game.
    McGuire A
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):5-6. PubMed ID: 22280188
    [No Abstract]   [Full Text] [Related]  

  • 31. New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.
    Antoñanzas F; Gómez P
    Pharmacoeconomics; 2010; 28(11):977-80. PubMed ID: 20936881
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential pricing of new pharmaceuticals in lower income European countries.
    Kaló Z; Annemans L; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?
    Mestre-Ferrandiz J; Zozaya N; Alcalá B; Hidalgo-Vega Á
    Pharmacoeconomics; 2018 Dec; 36(12):1407-1420. PubMed ID: 30198061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceutical expenditure and therapeutic value of new medicines in Spain.
    Darba J
    Pharmacoeconomics; 2003; 21(16):1211-2. PubMed ID: 14594440
    [No Abstract]   [Full Text] [Related]  

  • 36. Defining the concept of fair pricing for medicines.
    Moon S; Mariat S; Kamae I; Pedersen HB
    BMJ; 2020 Jan; 368():l4726. PubMed ID: 31932334
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medications: dear and expensive?].
    Rojahn J
    Klin Monbl Augenheilkd; 2014 Feb; 231(2):108-13. PubMed ID: 25298981
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical industry pricing practices: impact of the Bayer settlement.
    Berkle M
    Health Care Law Mon; 2001 Jul; ():3-11. PubMed ID: 11484634
    [No Abstract]   [Full Text] [Related]  

  • 39. The ethics and economics of pharmaceutical pricing.
    Parker-Lue S; Santoro M; Koski G
    Annu Rev Pharmacol Toxicol; 2015; 55():191-206. PubMed ID: 25149920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global Generic Medicines--Health Network Communications' Second Annual Summit.
    Burck B
    IDrugs; 2008 May; 11(5):328-30. PubMed ID: 18465671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.